Join
Live feed
·
PRReleasevia Quantisnow
Cingulate Inc. logo

Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology

ByQuantisnow·Wall Street's wire, on your screen.
CING· Cingulate Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CING (Cingulate Inc.) and more on Quantisnow.